199 related articles for article (PubMed ID: 17553037)
1. The challenge of follow-up in narrowband ultraviolet B phototherapy.
Diffey BL; Farr PM
Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
Kirke SM; Lowder S; Lloyd JJ; Diffey BL; Matthews JN; Farr PM
J Invest Dermatol; 2007 Jul; 127(7):1641-6. PubMed ID: 17380117
[TBL] [Abstract][Full Text] [Related]
3. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
4. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
5. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
6. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
Ortiz-Salvador JM; Ferrer DS; Saneleuterio-Temporal M; Victoria Martínez AM; Ferriols AP; Vilata Corell JJ; Alegre de Miquel V
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
[TBL] [Abstract][Full Text] [Related]
7. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
Man I; Crombie IK; Dawe RS; Ibbotson SH; Ferguson J
Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
Raone B; Patrizi A; Gurioli C; Gazzola A; Ravaioli GM
Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483
[TBL] [Abstract][Full Text] [Related]
9. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Weischer M; Blum A; Eberhard F; Röcken M; Berneburg M
Acta Derm Venereol; 2004; 84(5):370-4. PubMed ID: 15370703
[TBL] [Abstract][Full Text] [Related]
10. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
11. The risk of skin cancer in psoriasis patients treated with UVB therapy.
Osmancevic A; Gillstedt M; Wennberg AM; Larkö O
Acta Derm Venereol; 2014 Jul; 94(4):425-30. PubMed ID: 24322826
[TBL] [Abstract][Full Text] [Related]
12. A new development in UVB phototherapy of psoriasis.
van Weelden H; De La Faille HB; Young E; van der Leun JC
Br J Dermatol; 1988 Jul; 119(1):11-9. PubMed ID: 3408653
[TBL] [Abstract][Full Text] [Related]
13. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
[TBL] [Abstract][Full Text] [Related]
14. Paediatric psoriasis--narrowband UVB treatment.
Zamberk P; Velázquez D; Campos M; Hernanz JM; Lázaro P
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):415-9. PubMed ID: 19754659
[TBL] [Abstract][Full Text] [Related]
15. Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.
Otman SG; Edwards C; Gambles B; Anstey AV
Br J Dermatol; 2006 Aug; 155(2):416-21. PubMed ID: 16882183
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy.
Lim C; Brown P
Australas J Dermatol; 2006 Feb; 47(1):37-40. PubMed ID: 16405481
[TBL] [Abstract][Full Text] [Related]
17. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
18. PUVA, UVB, psoriasis, and nonmelanoma skin cancer.
Studniberg HM; Weller P
J Am Acad Dermatol; 1993 Dec; 29(6):1013-22. PubMed ID: 8245237
[TBL] [Abstract][Full Text] [Related]
19. Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting.
Yule S; Sanyal S; Ibbotson S; Moseley H; Dawe RS
Br J Dermatol; 2013 Aug; 169(2):464-8. PubMed ID: 23488569
[TBL] [Abstract][Full Text] [Related]
20. Narrowband ultraviolet B (UVB) phototherapy in children.
Jury CS; McHenry P; Burden AD; Lever R; Bilsland D
Clin Exp Dermatol; 2006 Mar; 31(2):196-9. PubMed ID: 16487089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
